» Articles » PMID: 38062018

Degenerative Mitral Regurgitation

Overview
Specialty General Medicine
Date 2023 Dec 7
PMID 38062018
Authors
Affiliations
Soon will be listed here.
Abstract

Degenerative mitral regurgitation is a major threat to public health and affects at least 24 million people worldwide, with an estimated 0.88 million disability-adjusted life years and 34,000 deaths in 2019. Improving access to diagnostic testing and to timely curative therapies such as surgical mitral valve repair will improve the outcomes of many individuals. Imaging such as echocardiography and cardiac magnetic resonance allow accurate diagnosis and have provided new insights for a better definition of the most appropriate timing for intervention. Advances in surgical techniques allow minimally invasive treatment with durable results that last for ≥20 years. Transcatheter therapies can provide good results in select patients who are considered high risk for surgery and have a suitable anatomy; the durability of such repairs is up to 5 years. Translational science has provided new knowledge on the pathophysiology of degenerative mitral regurgitation and may pave the road to the development of medical therapies that could be used to halt the progression of the disease.

Citing Articles

Contemporary Outcomes of Degenerative Mitral Valve Surgery in a Regional Tertiary Care Center.

Berretta P, Galeazzi M, Spagnolo F, Giusti M, DAlessio S, Bifulco O J Clin Med. 2024; 13(22).

PMID: 39597894 PMC: 11595119. DOI: 10.3390/jcm13226751.


Wearable device-measured moderate to vigorous physical activity and risk of degenerative aortic valve stenosis.

Li Z, Cheng S, Guo B, Ding L, Liang Y, Shen Y Eur Heart J. 2024; 46(7):649-664.

PMID: 38953786 PMC: 11825145. DOI: 10.1093/eurheartj/ehae406.

References
1.
Liu B, Edwards N, Pennell D, Steeds R . The evolving role of cardiac magnetic resonance in primary mitral regurgitation: ready for prime time?. Eur Heart J Cardiovasc Imaging. 2018; 20(2):123-130. PMC: 6343082. DOI: 10.1093/ehjci/jey147. View

2.
van Wijngaarden A, Hiemstra Y, Koopmann T, Ruivenkamp C, Aten E, Schalij M . Identification of known and unknown genes associated with mitral valve prolapse using an exome slice methodology. J Med Genet. 2020; 57(12):843-850. DOI: 10.1136/jmedgenet-2019-106715. View

3.
Perazzolo Marra M, Basso C, De Lazzari M, Rizzo S, Cipriani A, Giorgi B . Morphofunctional Abnormalities of Mitral Annulus and Arrhythmic Mitral Valve Prolapse. Circ Cardiovasc Imaging. 2016; 9(8):e005030. PMC: 4991345. DOI: 10.1161/CIRCIMAGING.116.005030. View

4.
Ajmone Marsan N, Delgado V, Shah D, Pellikka P, Bax J, Treibel T . Valvular heart disease: shifting the focus to the myocardium. Eur Heart J. 2022; 44(1):28-40. PMC: 9805407. DOI: 10.1093/eurheartj/ehac504. View

5.
Tromp J, Seekings P, Hung C, Iversen M, Frost M, Ouwerkerk W . Automated interpretation of systolic and diastolic function on the echocardiogram: a multicohort study. Lancet Digit Health. 2021; 4(1):e46-e54. DOI: 10.1016/S2589-7500(21)00235-1. View